Stock analysts at JPMorgan Chase & Co. set a $110.00 target price on shares of Humana (NYSE:HUM) stock in a report issued on Thursday, StockRatingsNetwork reports. JPMorgan Chase & Co.’s price objective points to a potential upside of 16.16% from the company’s current price.
A number of other firms have also recently commented on HUM. Analysts at Zacks downgraded shares of Humana (NYSE:HUM) from an “outperform” rating to a “neutral” rating in a research note to investors on Wednesday. They now have a $99.00 price target on the stock. Separately, analysts at Cantor Fitzgerald raised their price target on shares of Humana (NYSE:HUM) from $90.00 to $105.00 in a research note to investors on Wednesday, August 14th. They now have a “buy” rating on the stock. Finally, analysts at Goldman Sachs Group Inc. reiterated a “sell” rating on shares of Humana (NYSE:HUM) in a research note to investors on Thursday, August 8th.
One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have issued a buy rating to the company’s stock. Humana currently has a consensus rating of “Buy” and a consensus price target of $96.95.
Shares of Humana (NYSE:HUM) opened at 94.70 on Thursday. Humana has a 52 week low of $63.93 and a 52 week high of $94.70. The stock has a 50-day moving average of $91.66 and a 200-day moving average of $80.59. The company has a market cap of $14.817 billion and a price-to-earnings ratio of 10.08.
Humana (NYSE:HUM) last released its earnings data on Wednesday, July 31st. The company reported $2.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.46 by $0.17. The company had revenue of $10.32 billion for the quarter, compared to the consensus estimate of $10.36 billion. During the same quarter in the previous year, the company posted $2.16 earnings per share. The company’s revenue for the quarter was up 6.4% on a year-over-year basis. On average, analysts predict that Humana will post $8.76 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Friday, October 25th. Shareholders of record on Monday, September 30th will be paid a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 1.14%. The ex-dividend date is Thursday, September 26th.
In other Humana news, VP Heidi Margulis sold 3,319 shares of the company’s stock on the open market in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $93.35, for a total transaction of $309,828.65. Following the completion of the sale, the vice president now directly owns 10,801 shares in the company. The sale was disclosed in a legal filing with the SEC, which is available at this link.
Humana Inc (NYSE:HUM) is a health care company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.